D.O.T.S AINEWS
Live
OpenAI announces GPT-5 with unprecedented reasoning capabilitiesGoogle DeepMind achieves breakthrough in protein folding for rare diseasesEU passes landmark AI Safety Act with global implicationsAnthropic raises $7B as enterprise demand for Claude surgesMeta open-sources Llama 4 with 1T parameter modelNVIDIA unveils next-gen Blackwell Ultra chips for AI data centersApple integrates on-device AI across entire product lineupSam Altman testifies before Congress on AI regulation frameworkMistral AI reaches $10B valuation after Series C funding roundStability AI launches video generation model rivaling SoraOpenAI announces GPT-5 with unprecedented reasoning capabilitiesGoogle DeepMind achieves breakthrough in protein folding for rare diseasesEU passes landmark AI Safety Act with global implicationsAnthropic raises $7B as enterprise demand for Claude surgesMeta open-sources Llama 4 with 1T parameter modelNVIDIA unveils next-gen Blackwell Ultra chips for AI data centersApple integrates on-device AI across entire product lineupSam Altman testifies before Congress on AI regulation frameworkMistral AI reaches $10B valuation after Series C funding roundStability AI launches video generation model rivaling Sora

Pharmaceuticals

1 article tagged "Pharmaceuticals"

Eli Lilly Forges Landmark $2.75 Billion Alliance with AI Drug Pioneer Insilico Medicine
Industry2 min read

Eli Lilly Forges Landmark $2.75 Billion Alliance with AI Drug Pioneer Insilico Medicine

Pharmaceutical titan Eli Lilly has entered a $2.75 billion agreement with Insilico Medicine, a pioneer in AI-driven drug discovery. This collaboration underscores a pivotal shift in pharmaceutical R&D, leveraging generative AI and reinforcement learning for novel therapeutic development.

D.O.T.S AI NewsroomD.O.T.S AI Newsroom2 min read